This “formula” is not very enlightening and a physician who wrote for further details was told that Hyperol contained: Hydrastin 1/40 gr. Aloin 1/12 gr. Iron salts 3 gr. Apiol (Special) 3 ♏ Ergotin 1 gr. And excipients. If this is correct, then, so far as its active ingredients are concerned, Hyperol is but a mixture of well-known drugs, having contradictory properties. According to the claims in the circular quoted above, it is useful both in amenorrhea and in menorrhagia. The mixture is as unscientific as it is unnecessary. It cannot be adapted to any individual case; when ergot is indicated, apiol would naturally be contra-indicated; if aloes is appropriate, hydrastis may defeat the object sought. It is unnecessary because no intelligent physician would prescribe such a combination of drugs in any given case. The claims are exaggerated, improbable and foolish. Hyperol conflicts with the following rules of the Council: _Rule 4_, in that statements on the label and in the circular enclosed with the trade package advertise it to the public in the treatment of diseases. _Rule 6_, in that exaggerated and unwarranted claims are made for its therapeutic qualities. _Rule 8_, in that the name of this pharmaceutical mixture fails to disclose the potent constituents. _Rule 10_, in that it is unscientific. It is recommended that publication of this report be authorized to call attention to the unscientific character of such complex mixtures. [Editor’s Note: Hyperol is advertised in _American Medicine_ and the _St. Paul Medical Journal_.]--(_From The Journal A. M. A., April 18, 1914._) INGLUVIN Report of the Council on Pharmacy and Chemistry A subcommittee of the Council reported that unwarranted claims and misrepresentation were made for Ingluvin by its manufacturers, William R. Warner & Co., recommended that the preparation be refused recognition and that the report be submitted to Warner & Co. for action. The report was submitted to the firm, and after waiting one month and no acknowledgement or reply having been received, the Council directed its publication. It is as follows: REPORT ON INGLUVIN Ingluvin is manufactured by W. R. Warner & Co., chemists, Philadelphia, Pa. The printed matter contains numerous claims and representations of which the following are specimens: